JP2014503599A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014503599A5 JP2014503599A5 JP2013551904A JP2013551904A JP2014503599A5 JP 2014503599 A5 JP2014503599 A5 JP 2014503599A5 JP 2013551904 A JP2013551904 A JP 2013551904A JP 2013551904 A JP2013551904 A JP 2013551904A JP 2014503599 A5 JP2014503599 A5 JP 2014503599A5
- Authority
- JP
- Japan
- Prior art keywords
- octane
- azabicyclo
- oxo
- pyridinecarboxamide
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2011-0008960 | 2011-01-28 | ||
| KR20110008960 | 2011-01-28 | ||
| PCT/KR2012/000648 WO2012102580A1 (en) | 2011-01-28 | 2012-01-30 | Pharmaceutical composition comprising pyridone derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014503599A JP2014503599A (ja) | 2014-02-13 |
| JP2014503599A5 true JP2014503599A5 (enExample) | 2014-12-25 |
| JP5921576B2 JP5921576B2 (ja) | 2016-05-24 |
Family
ID=46581019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013551904A Expired - Fee Related JP5921576B2 (ja) | 2011-01-28 | 2012-01-30 | ピリドン誘導体を含む医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8716309B2 (enExample) |
| EP (1) | EP2668186B1 (enExample) |
| JP (1) | JP5921576B2 (enExample) |
| KR (1) | KR101925971B1 (enExample) |
| CN (1) | CN103328477B (enExample) |
| CA (1) | CA2824467C (enExample) |
| ES (1) | ES2634204T3 (enExample) |
| WO (1) | WO2012102580A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101928505B1 (ko) * | 2011-01-28 | 2018-12-12 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| RU2692485C2 (ru) | 2014-04-02 | 2019-06-25 | Интермьюн, Инк. | Противофиброзные пиридиноны |
| US10111867B2 (en) | 2015-02-17 | 2018-10-30 | Mapi Pharma Ltd. | Process and intermediates for the preparation of perampanel |
| US9840481B2 (en) | 2016-03-22 | 2017-12-12 | Merck Sharp & Dohme Corp. | Allosteric modulators of nicotinic acetylcholine receptors |
| CA3108048A1 (en) * | 2017-07-31 | 2019-02-07 | Washington University | Pirfenidone derivatives for modulation of b lymphocyte activity and organ protection |
| JOP20200272A1 (ar) | 2018-05-01 | 2020-11-01 | Merck Sharp & Dohme | مُعدّلات تفارغية سبيروبيريدين لمستقبلات أستيل كولين نيكوتينية |
| CN109293507B (zh) * | 2018-10-12 | 2020-12-18 | 河北科技大学 | 4-甲氧基甲烯基-2-烯戊二酸二甲酯的合成方法及其应用 |
| US12534458B2 (en) | 2019-11-05 | 2026-01-27 | Merck Sharp & Dohme Llc | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4404138A (en) * | 1982-06-22 | 1983-09-13 | Warner-Lambert Company | 3-[2-(Azabicyclo) ethyl]-1,2,3,4-tetrahydro-5H-[1]benzopyrano[3,4-c]pyridin-5-ones |
| EP1147112B1 (en) * | 1999-01-29 | 2003-10-29 | Abbott Laboratories | Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| US6569865B2 (en) * | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
| JP2005510482A (ja) * | 2001-10-16 | 2005-04-21 | アストラゼネカ・アクチエボラーグ | 線維筋痛症候群の治療方法 |
| FR2834511B1 (fr) | 2002-01-07 | 2004-02-13 | Sanofi Synthelabo | Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique |
| WO2010042799A2 (en) * | 2008-10-09 | 2010-04-15 | Howard Hughes Medical Institute | Novel chimeric ligand-gated ion channels and methods of use thereof |
| CN102209540A (zh) * | 2008-11-11 | 2011-10-05 | 塔加西普特公司 | 使用α7-选择性配体的治疗方法 |
| KR101928505B1 (ko) * | 2011-01-28 | 2018-12-12 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
-
2012
- 2012-01-27 KR KR1020120008536A patent/KR101925971B1/ko active Active
- 2012-01-30 ES ES12740018.2T patent/ES2634204T3/es active Active
- 2012-01-30 CN CN201280006741.XA patent/CN103328477B/zh active Active
- 2012-01-30 JP JP2013551904A patent/JP5921576B2/ja not_active Expired - Fee Related
- 2012-01-30 US US13/980,819 patent/US8716309B2/en not_active Expired - Fee Related
- 2012-01-30 EP EP12740018.2A patent/EP2668186B1/en active Active
- 2012-01-30 WO PCT/KR2012/000648 patent/WO2012102580A1/en not_active Ceased
- 2012-01-30 CA CA2824467A patent/CA2824467C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2526544T3 (es) | Derivado de ácido aminocarboxílico y uso médico del mismo | |
| JP2008516986A5 (enExample) | ||
| PH12019501707A1 (en) | N-[4-fluoro-5-[[(2s,4s)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]-1-piperidyl]methyl]thiazol-2-yl]acetamide as oga inhibitor | |
| JP2011503103A5 (enExample) | ||
| RU2009133794A (ru) | Гербициды на основе замещенного n-оксида пиридина | |
| JP2020502092A5 (enExample) | ||
| PE20090435A1 (es) | Inhibidores de tetrahidropiranocromeno de gamma secretasa | |
| JP2017214387A5 (enExample) | ||
| JP2019505541A5 (enExample) | ||
| JP2014526549A5 (enExample) | ||
| BRPI0518360A2 (pt) | composto e sais farmaceuticamente aceitÁveis do mesmo, composiÇço farmacÊutica, uso de um composto, e, processo para preparar um composto ou um sal farmaceuticamente aceitÁvel do mesmo | |
| JP2017522374A5 (enExample) | ||
| RU2018103198A (ru) | Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов | |
| JP2005502661A5 (enExample) | ||
| WO2002085901A8 (en) | Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists) | |
| NZ579296A (en) | Spirocyclic compounds as inhibitors of serine proteases for the treatment of HCV infections | |
| JP2021514400A5 (enExample) | ||
| JP2017511378A5 (enExample) | ||
| JP2018509451A5 (enExample) | ||
| JP2005506308A5 (enExample) | ||
| JP2017502063A5 (enExample) | ||
| JP2012518634A5 (enExample) | ||
| NO20075022L (no) | (7-(2-(4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyrid-1-yl)etyl) isokinolinbesylatsalt, fremstilling og terapeutiske anvendelser derav | |
| PE20201151A1 (es) | Moduladores alostericos positivos del receptor de dopamina d1 | |
| TW200626573A (en) | Pyrimidone compound |